Abstracts

DISTINCT CHROMOSOMAL INTEGRATION SITE CONFIGURATION IN HIV-1 ELITE CONTROLLERS

HIV-1 elite controllers (EC) represent a rare group (< 0.5%) of infected individuals who maintain undetectable viral loads in the absence of antiretroviral therapy (ART). However, the distinguishing features of proviral reservoir cells in these individuals are unclear. Matched integration site and proviral sequencing (MIP-Seq) was applied to PBMC from 11 EC to investigate chromosomal integration…

CHIMERIC ANTIGEN RECEPTOR T CELLS CONTROL SHIV REPLICATION IN POST-ATI MACAQUES

An effective strategy to achieve antiretroviral therapy (ART)-free remission in HIV+ individuals will likely require active and passive approaches. We optimized CD4-based Chimeric Antigen Receptor (CD4CAR) molecules to actively target infected cells, and combined with CCR5 editing to passively protect CD4CAR T cells against infection. This approach was modeled in nonhuman primates (NHPs) infected with…

DELAY IN VIRAL REBOUND WITH TLR7 AGONIST, N6-LS, AND PGT121 IN SHIV-INFECTED MACAQUES

Toll-like receptor (TLR)-7 agonist and PGT121 administration have previously delayed viral rebound and induced SHIV remission after antiretroviral therapy (ART) interruption in macaques that started ART 7 days post SHIV-SF162P3 infection. We evaluated the impact of TLR-7 agonist and dual broadly neutralizing antibodies (bnAb) on viral rebound in SHIV-infected macaques. Male rhesus macaques (n=16), pre-screened to…

COMBINED ACTIVE AND PASSIVE IMMUNIZATION IN SHIV-INFECTED RHESUS MONKEYS

Our group and others have previously reported that therapeutic immunization can result in post-rebound virologic control in SHIV-infected rhesus monkeys following ART discontinuation, and that administration of broadly neutralizing antibodies (bNAbs) can delay or prevent viral rebound.  The potential of combined active and passive immunization as an HIV-1 cure strategy has not previously been evaluated.…

COMBINATION IL-15 THERAPY IN A SHIV NHP MODEL

Latent reservoirs of replication-competent HIV-1 persist in patients on anti-retroviral therapy (ART) and represent the major obstacle to HIV eradication efforts. Considerable effort has been directed to develop and evaluate novel remission strategies to enhance virus-specific immune responses in ART-suppressed patients. We conducted 2 studies in SHIV-infected ART-suppressed rhesus macaques (RM) to evaluate the IL-15…

WHOLE-BODY PET IMAGING OF THE HIV RESERVOIR USING RADIOLABELED VRC01

HIV largely resides in anatomical regions that are inaccessible to routine sampling, and non-invasive methods to understand the tissue-wide burden of HIV are urgently needed. We report on the first-in-human PET-magnetic resonance (MR) imaging studies of HIV infection using a radiolabeled HIV Env-specific mAb, 89Zr-VRC01.   PET-MR imaging using 89Zr-VRC01 (t1/2=73h) was performed on 5…